Novel Small Molecules Product types and Advanced Imaging Technologies: Analyzing Disease Modification Comparison and End-Stage Kidney Disease Impact for North American Locations
Despite the breakthrough of V2 receptor antagonists, the therapeutic need for additional and more effective treatments for Autosomal Dominant Polycystic Kidney Disease (ADPKD) remains high. The research pipeline is robust with Novel Small Molecules Product types targeting various other mechanisms implicated in cystogenesis, such as cell cycle dysregulation, apoptosis, and...
0 Commentarios 0 Acciones 261 Views 0 Vista previa